Skip to main content
. 2020 Jul 28;25(5):775–779. doi: 10.1016/j.rpor.2020.07.003

Fig. 4.

Fig. 4

Reasons for not adhering with the new guidelines. 32.4% believe that normofractionated RT is the better concept. 33% voiced concerns about increased side effects. 19.3% indicated that the underlying data was insufficient. 19.9% put financing as their reason.